BRCA1 and neoplasm: A single-cell RNA sequencing (scRNA-seq) study involving tumor adjacent normal or prophylactic surgery of BRCA1 mutation carriers and three non-carriers suggested that breast cancers in BRCA1 mutation carriers originate from luminal progenitors, as suggested previously using flow cytometry and bulk RNA sequencing (4, 7).